Back
Day Range
$0.72
$0.80
52-Week Range
$0.60
$0.83
Volume
3,000
50D / 200D Avg
$0.75
/
$0.76
Prev Close
$0.80
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 20.9 | 0.4 |
| P/B | 1.4 | 2.9 |
| ROE % | 6.7 | 3.8 |
| Net Margin % | 9.2 | 3.9 |
| Rev Growth 5Y % | 1.4 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.04
$0.04 – $0.04
|
870 M | 1 |
| FY2027 |
$0.03
$0.03 – $0.03
|
830 M | 1 |
| FY2026 |
$0.03
$0.03 – $0.03
|
790 M | 1 |
Key Takeaways
Revenue grew 1.38% annually over 5 years — modest growth
Debt/Equity of 0.11 — conservative balance sheet
Generating 98.04M in free cash flow
Cash machine — converts 139.03% of earnings into free cash flow
Capital efficient — spends only 1.03% of revenue on capex
Growth
Revenue Growth (5Y)
1.38%
Revenue (1Y)1.75%
Earnings (1Y)13.29%
FCF Growth (3Y)-23.79%
Quality
Return on Equity
6.69%
ROIC5.84%
Net Margin9.22%
Op. Margin11.93%
Safety
Debt / Equity
0.11
Current Ratio1.31
Interest Coverage22.30
Valuation
P/E Ratio
20.88
P/B Ratio1.39
EV/EBITDA13.98
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.75% | Revenue Growth (3Y) | 3.93% |
| Earnings Growth (1Y) | 13.29% | Earnings Growth (3Y) | -11.56% |
| Revenue Growth (5Y) | 1.38% | Earnings Growth (5Y) | -4.33% |
| Profitability | |||
| Revenue (TTM) | 764.73M | Net Income (TTM) | 70.52M |
| ROE | 6.69% | ROA | 4.94% |
| Gross Margin | 17.87% | Operating Margin | 11.93% |
| Net Margin | 9.22% | Free Cash Flow (TTM) | 98.04M |
| ROIC | 5.84% | FCF Growth (3Y) | -23.79% |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 1.31 |
| Interest Coverage | 22.30 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 20.88 | P/B Ratio | 1.39 |
| P/S Ratio | 1.93 | PEG Ratio | 1.77 |
| EV/EBITDA | 13.98 | Dividend Yield | 0.03% |
| Market Cap | 1.47B | Enterprise Value | 1.28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 764.73M | 751.56M | 708.03M | 822.92M | 723.79M |
| Net Income | 70.52M | 62.24M | 90.15M | 143.21M | 84.17M |
| EPS (Diluted) | 0.04 | 0.03 | 0.05 | 0.08 | 0.04 |
| Gross Profit | 136.63M | 486.14M | 315.94M | 639.98M | 580.52M |
| Operating Income | 91.27M | 82.49M | 115.76M | 195.85M | 121.31M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.43B | 1.53B | 1.53B | 1.50B | 1.55B |
| Total Liabilities | 373.70M | 465.82M | 484.38M | 467.30M | 568.67M |
| Shareholders' Equity | 1.06B | 1.05B | 1.03B | 1.02B | 960.79M |
| Total Debt | 114.76M | 88.17M | 124.70M | 96.14M | 198.13M |
| Cash & Equivalents | 310.56M | 343.67M | 343.60M | 253.13M | 264.99M |
| Current Assets | 435.48M | 516.32M | 484.70M | 494.35M | 439.10M |
| Current Liabilities | 333.33M | 381.94M | 379.38M | 362.99M | 416.61M |